Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ¾à¹°Àü´Þ > Drug Delivery - Snapshots and Highlights
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

Drug Delivery - Snapshots and Highlights

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2007³â 04¿ù »óǰÄÚµå 51407
ÆäÀÌÁö Á¤º¸ 46 Pages
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This research service discusses technology and strategy trends relative to the drug delivery market. It provides overview snapshots and highlights of drug delivery technology sector topics for implant delivery, oral modified release, and nanobiotechnology. Also discussed are business strategy trends currently important in drug delivery relative to business development, licensing, and lifecycle management.

Table of Contents

1 EXECUTIVE SUMMARY

  • Executive Summary
    • Introduction
  • Drug Delivery Topics
    • Overview and Scope

2 SNAPSHOTS AND HIGHLIGHTS

  • Technology
    • Implant Technologies: Expected to Remain a Niche but Effective Method of Drug Delivery
    • Oral Extended Release: Snapshots and Benefits
    • Oral Controlled Release: Necessity or Compulsion?
    • Nanobiotechnology: Delivering Revenue and Exciting Promise for the Future
  • Business and Strategy
    • Drug Delivery' s Increasing Importance to Big Pharma and Specialty Pharma
    • Drug Delivery is Integral to Lifecycle Strategies

3 APPENDIX

  • Decision Support Databases
    • Number of Biotechnology Companies
    • Pharmaceutical R&D Expenditure
    • Pharmaceutical R&D Expenditure As Percentage of Pharmaceutical Market
    • Total Healthcare Expenditure
    • Total Population
Back to Top